-
EP2769737
European procedure
Extract from the Register of European Patents
EP About this file: EP2769737
| EP2769737 - Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.02.2018 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 03.03.2017 | ||
| Former | Grant of patent is intended Status updated on 19.12.2016 | Most recent event Tooltip | 09.02.2018 | No opposition filed within time limit | published on 14.03.2018 [2018/11] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [2017/14] |
| Former [2014/35] | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543-4000 / US | Inventor(s) | 01 /
Lee, Francis, Y. c/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ New Jersey 08543 / US | 02 /
Jure-Kunkel, Maria c/o Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ New Jersey 08543 / US | [2014/35] | Representative(s) | Reitstötter Kinzebach Patentanwälte Sternwartstraße 4 81679 München / DE | [N/P] |
| Former [2014/35] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 14162613.5 | 29.10.2009 | [2014/35] | Priority number, date | US20090226910P | 20.07.2009 Original published format: US 226910 P | US20090462168 | 30.07.2009 Original published format: US 462168 | WO2009US52209 | 30.07.2009 Original published format: PCT/US2009/052209 | [2014/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2769737 | Date: | 27.08.2014 | Language: | EN | [2014/35] | Type: | B1 Patent specification | No.: | EP2769737 | Date: | 05.04.2017 | Language: | EN | [2017/14] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.07.2014 | Classification | IPC: | A61K45/06, A61K39/395, A61K31/385, A61K31/506, A61K31/337, C07K16/28, A61K33/24, A61K39/00 | [2014/35] | CPC: |
A61K31/506 (EP,KR);
A61K33/243 (EP,US);
A61K31/337 (EP);
A61K31/385 (EP);
A61K39/395 (KR);
A61K39/39558 (EP);
A61K47/22 (KR);
A61K47/26 (KR);
A61P35/00 (EP);
A61P35/04 (EP);
A61P43/00 (EP);
C07K16/2818 (EP);
A61K2039/505 (EP)
(-)
| C-Set: |
A61K31/337, A61K2300/00 (EP);
A61K31/385, A61K2300/00 (EP);
A61K31/506, A61K2300/00 (EP);
A61K33/24, A61K2300/00 (EP); | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2017/14] |
| Former [2014/35] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | Kombination aus einem Anti-CTLA4-Antikörper mit Etoposide für die synergistische Behandlung proliferativer Erkrankungen | [2014/35] | English: | Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases | [2014/35] | French: | Combinaison d'anticorps anti-ctla4 avec etoposide pour le traitement synergique de prolifération | [2016/49] |
| Former [2014/37] | Combinaison d'anticorps anti-CTLA4 avec etoposide pour le traitement synergique de prolifération | Examination procedure | 11.11.2014 | Amendment by applicant (claims and/or description) | 11.11.2014 | Examination requested [2014/51] | 20.03.2015 | Despatch of a communication from the examining division (Time limit: M04) | 17.04.2015 | Reply to a communication from the examining division | 03.01.2017 | Communication of intention to grant the patent | 27.02.2017 | Fee for grant paid | 27.02.2017 | Fee for publishing/printing paid | 27.02.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09749268.0 / EP2456790 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20090749268) is 27.05.2013 | Opposition(s) | 08.01.2018 | No opposition filed within time limit [2018/11] | Fees paid | Renewal fee | 31.03.2014 | Renewal fee patent year 03 | 31.03.2014 | Renewal fee patent year 04 | 31.03.2014 | Renewal fee patent year 05 | 14.10.2014 | Renewal fee patent year 06 | 12.10.2015 | Renewal fee patent year 07 | 11.10.2016 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2004005318 (DAVIS THOMAS ANDREW [US], et al); | [XYI]US2005226875 (GOMEZ-NAVARRO JESUS [US], et al); | [XI]US2007160619 (NICHOL GEOFFREY M [US], et al); | [XYI]WO2007113648 (PFIZER PROD INC [US], et al); | [X]US2009117132 (READETT DAVID ROBERT JOHN [US], et al); | by applicant | WO8605807 | US4676980 | WO8901036 | EP0307434 | EP0367166 | US4946778 | WO9106570 | US5112946 | US5122464 | US5336603 | US5349053 | US5359046 | US5447851 | WO9604388 | US5504102 | US5622929 | WO9733899 | WO9734911 | US5811097 | WO9842752 | US5855887 | US5898031 | WO9923105 | WO9932619 | EP0928290 | US5977318 | US6011029 | US6051227 | WO0037504 | US6107094 | WO0114424 | US6207156 | WO0129058 | US6262094 | EP1144639 | US2002039581 | EP1214945 | US2002086014 | US6506559 | US2003051263 | US2003055020 | US2003056235 | EP1309726 | US6682736 | WO2004009769 | WO2004015130 | WO2004035607 | US2004265839 | US2005100913 | US2005201994 | US6984720 | US2006024798 | US7056704 | US7078196 | US7109003 | US7132281 | EP1212422 | US2007082365 | WO2007067959 | US7282564 | US2008050342 | US2008055443 | US2008081373 | US2008139791 | US7432249 | US7432250 | US2008248576 | US7538095 | US7560438 | US20030395503 | US20050051208 | US20060402502 |